eCite Digital Repository

Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era

Citation

Chalmers, D and Nicol, D and Kaye, J and Bell, J and Campbell, AV and Ho, CWL and Kato, K and Minari, J and Ho, C-H and Mitchell, C and Molnar-Gabor, F and Otlowski, M and Thiel, D and Fullerton, SM and Whitton, T, Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era, BMC Medical Ethics, 17, (39) pp. 1-14. ISSN 1472-6939 (2016) [Refereed Article]


Preview
PDF
589Kb
  

Copyright Statement

Copyright 2016 The Authors Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/

DOI: doi:10.1186/s12910-016-0124-2

Abstract

Biobanks have been heralded as essential tools for translating biomedical research into practice, driving precision medicine to improve pathways for global healthcare treatment and services. Many nations have established specific governance systems to facilitate research and to address the complex ethical, legal and social challenges that they present, but this has not lead to uniformity across the world. Despite significant progress in responding to the ethical, legal and social implications of biobanking, operational, sustainability and funding challenges continue to emerge. No coherent strategy has yet been identified for addressing them. This has brought into question the overall viability and usefulness of biobanks in light of the significant resources required to keep them running. This review sets out the challenges that the biobanking community has had to overcome since their inception in the early 2000s. The first section provides a brief outline of the diversity in biobank and regulatory architecture in seven countries: Australia, Germany, Japan, Singapore, Taiwan, the UK, and the USA. The article then discusses four waves of responses to biobanking challenges. This article had its genesis in a discussion on biobanks during the Centre for Health, Law and Emerging Technologies (HeLEX) conference in Oxford UK, co-sponsored by the Centre for Law and Genetics (University of Tasmania). This article aims to provide a review of the issues associated with biobank practices and governance, with a view to informing the future course of both large-scale and smaller scale biobanks.

Item Details

Item Type:Refereed Article
Keywords:biobanks, sustainable biobanking, comparative review, medical research ethics, genetics and genomics, personalised medicine, precision medicine
Research Division:Law and Legal Studies
Research Group:Law
Research Field:Law not elsewhere classified
Objective Division:Law, Politics and Community Services
Objective Group:Justice and the Law
Objective Field:Justice and the Law not elsewhere classified
Author:Chalmers, D (Professor Don Chalmers)
Author:Nicol, D (Professor Dianne Nicol)
Author:Otlowski, M (Professor Margaret Otlowski)
Author:Whitton, T (Ms Tess Whitton)
ID Code:110110
Year Published:2016
Web of Science® Times Cited:8
Deposited By:Law
Deposited On:2016-07-13
Last Modified:2017-10-17
Downloads:47 View Download Statistics

Repository Staff Only: item control page